BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
- Tuesday, February 21, 2023, 7:12
- PR Newswire
- Add a comment
Expands Access to BD HPV Test that More Precisely Identifies Patients’ Risk for Cervical Cancer FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug…
About the Author
admin has written 20655 stories on this site.